Myriad Genetics

With the most inclusive groups and categories in healthcare advertising, the #AsterAwards are the nation’s most elite competition dedicated to recognizing the most talented healthcare marketing professionals for outstanding excellence in advertising, marketing and communications. Congratulations to our #WomensHealth teammates and partners at S50 and The Verdi Group for this three-time win!

Today we announced that the United States Patent and Trademark Office has issued a second foundational patent that will strengthen our ability to deliver a tumor-informed, high-definition, molecular residual disease (MRD) assay to market. “The issuance of this second patent supporting our MRD assay development showcases another dimension of Myriad’s novel proprietary technology that we believe will help advance Myriad’s position as a precision medicine leader—both via its own Precise MRD offering and via potential licensing opportunities in the MRD space,” said Paul Diaz, president and CEO, Myriad Genetics. “We have developed our Precise® MRD assay by leveraging Myriad’s existing technology – laboratory systems, infrastructure, and intellectual property – and by building upon our FDA-approved MyChoice® CDx companion diagnostic and FirstGene platforms. We believe that our unique set of capabilities will enable us to profitably commercialize Precise MRD, advancing oncology care for patients in this emerging and under-penetrated market.” Read the press release below.

We are excited to be at the #ISPD2024 conference in Boston, MA this week. Stop by booth #113 during exhibit hours to learn how we can support you and your patients through prenatal care. Be sure to also check out the two poster presentations we have today. Learn more about them below!

We're happy to announce that we've earned the 2024 Great Place To Work US Certification™ for the second year in a row! “At Myriad Genetics we are committed to fostering an open, collaborative and inclusive work environment where all teammates have an equal opportunity to grow and make a difference in our patients’ lives,” said Shereen Solaiman, chief people officer, Myriad Genetics. “The Great Place to Work Certification is a testament to the passion, talent and hard work our teammates bring to the Myriad workforce every day to fulfill our mission to advance health and well-being for all.” Read the press release below.

Holly Pederson MD and Myriad’s Elisha Hughes sat down with Oncology Data Advisor’s Keira Smith to discuss recent research shared at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting. They discuss the evaluation of a polygenic risk score as a predictor of early onset triple-negative breast cancer in Black women. 🎧 Listen to the podcast: https://brnw.ch/21wKWYz

Today we released the findings from our latest GeneSight® Mental Health Monitor, which revealed a significant 40% of Americans report feeling ‘depressed and/or anxious’ around the election season. “We hope that Americans will consider taking steps to improve their mental health as we get closer to this important election. The GeneSight test is one of the tools I’ve used to help my patients get back on the road to mental wellness,” said Thomas Valente, a psychiatrist from Leesburg, Florida. Read the press release below.

Excited to see our own Lesley A. Manley included in this impressive list from Utah Business. This #Top100 recognizes exceptional legal knowledge, ethical standards and professional accomplishments that have made impacted their field. Congrats, Lesley! #legalElite #teamrecognition

At Myriad, we believe that all patients should have access to an accurate picture of their breast cancer risk, which is why we validated our breast cancer risk assessment tool MyRisk with RiskScore in 2021 for women of all ancestries. Working with industry leading researchers, we assessed data from more than 275,000 women to validate our enhanced method for assessing polygenic breast cancer risk assessments in women across ancestries. Similar to the important work outlined in this latest article linked below, it's important to continue to support research that helps to address ethnic disparities in healthcare to protect #healthequity for all. #advancingcare #breastcancer

Love to see the industry recognition of great work well done by our team! 🏆   This achievement is a reflection of the dedication, creativity, and hard work that we see in action across our teams all the time. Let's continue to push the boundaries and set new standards in our industry. Here's to many more successes together! 🚀 Congratulations!   #AsterAwards #WomensHealth #WinningTeam

Salt Lake City is our hometown, and we take our community seriously. Thanks to all the friends and family who joined this year’s #SailFest2024 to support the environmental rejuvenation of the Great Salt Lake and learn how we can contribute to preserving this incredible local resource. Thanks to the #GrowTheFlow Conserve Utah Valley team for such a great event! Many thanks to our local teammates who helped create and capture this event! Karl Lundeberg Karla Bowles Spring Taylor Tisa Conran #localpartners #environment #conservation